Robert M. Califf

Professor of Medicine
Donald F. Fortin, M.D. Professor of Cardiology, in the School of Medicine
Campus mail 2400 Pratt St Ste 7028, Durham, NC 27705
Phone (919) 668-8820
Email address robert.califf@duke.edu

Dr. Califf is currently on leave from Duke University.

Associated Faculty Labs

Publications

Granieri, MA, Webster, GD, and Peterson, AC. "Author Reply." Urology 91 (May 2016): 207-.

PMID
27083938
Scholars@Duke

Preiss, D, Haffner, SM, Thomas, LE, Sun, JL, Sattar, N, Yates, T, J Davies, M, McMurray, JJ, Holman, RR, Califf, RM, and Kraus, WE. "Change in levels of physical activity after diagnosis of type 2 diabetes: an observational analysis from the NAVIGATOR study." Diabetes, obesity & metabolism 16, no. 12 (December 2014): 1265-1268.

PMID
24861892
Scholars@Duke

de Barros e Silva, PG, Califf, RM, Sun, JL, McMurray, JJ, Holman, R, Haffner, S, Thomas, L, and Lopes, RD. "Chronic obstructive pulmonary disease and cardiovascular risk: insights from the NAVIGATOR trial." International journal of cardiology 176, no. 3 (October 2014): 1126-1128. (Letter)

PMID
25220176
Scholars@Duke

Hess, PL, Mirro, MJ, Diener, HC, Eikelboom, JW, Al-Khatib, SM, Hylek, EM, Bosworth, HB, Gersh, BJ, Singer, DE, Flaker, G, Mega, JL, Peterson, ED, Rumsfeld, JS, Steinberg, BA, Kakkar, AK, Califf, RM, and Granger, CB. "Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012." American heart journal 168, no. 3 (September 2014): 239-247.e1.

PMID
25173533
Scholars@Duke

Holman, RR, Sourij, H, and Califf, RM. "Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes--Authors' reply." Lancet (London, England) 384, no. 9948 (September 2014): 1097-1098. (Letter)

PMID
25241719
Full Text

Blazing, MA, Giugliano, RP, Cannon, CP, Musliner, TA, Tershakovec, AM, White, JA, Reist, C, McCagg, A, Braunwald, E, and Califf, RM. "Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population." American heart journal 168, no. 2 (August 2014): 205-12.e1.

PMID
25066560
Scholars@Duke

Harskamp, RE, Alexander, JH, Schulte, PJ, Brophy, CM, Mack, MJ, Peterson, ED, Williams, JB, Gibson, CM, Califf, RM, Kouchoukos, NT, Harrington, RA, Ferguson, TB, and Lopes, RD. "Vein graft preservation solutions, patency, and outcomes after coronary artery bypass graft surgery: follow-up from the PREVENT IV randomized clinical trial." JAMA surgery 149, no. 8 (August 2014): 798-805.

PMID
25073921
Scholars@Duke

Califf, RM. "The new era of clinical research: using data for multiple purposes." American heart journal 168, no. 2 (August 2014): 133-134.

PMID
25066550
Full Text

Hess, CN, Roe, MT, Gibson, CM, Temple, RJ, Pencina, MJ, Zarin, DA, Anstrom, KJ, Alexander, JH, Sherman, RE, Fiedorek, FT, Mahaffey, KW, Lee, KL, Chow, SC, Armstrong, PW, and Califf, RM. "Independent data monitoring committees: preparing a path for the future." American heart journal 168, no. 2 (August 2014): 135-41.e1.

PMID
25066551
Scholars@Duke

Bernardez-Pereira, S, Lopes, RD, Carrion, MJ, Santucci, EV, Soares, RM, de Oliveira Abreu, M, Laranjeira, LN, Ikeoka, DT, Zazula, AD, Moreira, FR, Cavalcanti, AB, Mesquita, ET, Peterson, ED, Califf, RM, and Berwanger, O. "Prevalence, characteristics, and predictors of early termination of cardiovascular clinical trials due to low recruitment: insights from the ClinicalTrials.gov registry." American heart journal 168, no. 2 (August 2014): 213-9.e1.

PMID
25066561
Scholars@Duke

Pages